GlassScriptPhysician profile
Jed W Howington
NPI 1417913070
$1,383.57
in general payments reported to CMS, 2019-2025
23 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $35.75 · 2021: $122 · 2022: $146 · 2023: $284 · 2024: $185 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $915.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $489.05 | 2019-2024 | Optune |
| Astrazeneca Pharmaceuticals LP | $126.33 | 2020-2025 | Imfinzi, Tagrisso |
| Boston Scientific Corporation | $100.61 | 2025 | Spaceoar Vue System - 10ml |
| Progenics Pharmaceuticals, INC. | $96.00 | 2022 | |
| Teleflex LLC | $95.03 | 2024-2025 | Barrigel |
| Blue Earth Diagnostics | $50.77 | 2022-2023 | |
| Bioprotect Medical, INC. | $45.22 | 2025 | Bioprotect Balloon Implant System |
| Medtronic USA, INC. | $43.12 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $30.65 | 2022 | |
| Merck Sharp & Dohme LLC | $29.18 | 2024 | Keytruda |
| Bayer Healthcare Pharmaceuticals INC. | $28.99 | 2025 | |
| Daiichi Sankyo INC. | $28.08 | 2025 | Enhertu |
| Novartis Pharmaceuticals Corporation | $27.47 | 2025 | |
| Pfizer INC. | $24.59 | 2025 | |
| Beone Medicines USA, INC. | $22.68 | 2025 | Brukinsa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $21.66 | 2025 | Ninlaro |
| Geron Corporation | $19.01 | 2025 | Rytelo |
| Varian Medical Systems, INC. | $18.53 | 2019 | |
| Medtronic, INC. | $18.44 | 2023 | Osteocool Rf Ablation System |
| Genmab U.S., INC. | $18.29 | 2025 | Epkinly |
| Brainlab, INC. | $18.14 | 2019 | |
| Azurity Pharmaceuticals, INC. | $17.62 | 2025 | Danziten |
| Genentech USA, INC. | $14.11 | 2025 | Polivy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jed Howington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.